US 11273150
Compositions and methods for the treatment of presbyopia
granted A61KA61K31/439A61K31/4409
Quick answer
US patent 11273150 (Compositions and methods for the treatment of presbyopia) held by Lenz Therapeutics, Inc. expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lenz Therapeutics, Inc.
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/439, A61K31/4409, A61K31/717, A61K45/06